The VAC2VAC project was presented on February 3rd, 2021 at the scientific conference “Towards replacement of animals for scientific purposes”. The virtual conference, organized by the European Commission, aims to accelerate the move away from using animals in science and testing. Main achievements of the VAC2VAC project were presented by Dr Shahjahan Shaid (GSK) in the session “Cutting edge science: latest scientific advances to improve research and testing toolbox”. The presentation can be downloaded here:
About VAC2VAC:
VAC2VAC “Vaccine batch to vaccine batch comparison by consistency testing” is a EVI-coordinated project that aims to demonstrate proof of concept of the consistency approach for batch release testing of established vaccines. This means that physicochemical, immunochemical, cell-based and/or multparametric tests - instead of animal tests - shall be used to ensure that each vaccine batch produced is consistent with a batch already proven to be safe and efficacious.
Read more about VAC2VAC > http://www.vac2vac.eu/about
The VAC2VAC project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement N- 115924. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.